Sung Lee sold $3.2M of Cytokinetics (CYTK)

Executed Jun 24, disclosed Jun 29, 5 days later, against a two-business-day limit.

Value, as filed

$3.2M

38,730 sh × $82.30

Executed

Jun 24

the trade date, as filed

Disclosed

Jun 29

5 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Sung Lee EVP, Chief Financial Officer profile →

Sung Lee (EVP, Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales, 1 filed past the two-business-day deadline), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $3.2M of CYTK (38,730 sh × $82.30, as filed), executed Jun 24.

The name

CYTK

Cytokinetics, Incorporated CYTK · Healthcare · 121 filings in 24 months ticker →

Healthcare · Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators an…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Sung Lee in CYTK

CYTKSALE Cytokinetics, Incorporated $266K
3,134 sh × $85.00
Exec Jun 29
Filed Jun 29 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $1.8M
23,906 sh × $76.87
Exec May 5
Filed May 5 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $307K
4,935 sh × $62.15
Exec Mar 17
Filed Mar 18 · 5:30 PM ET